|Scientific Subdivisions | The Journal of Molecular Diagnostics
Contact AMP | Sign In | Join / Renew | Go To CHAMP
AMP urged the House Energy and Commerce Committee to use AMP's CLIA modernization proposal as the basis for legislation where the goal is to preserve innovative patient care by building upon the current CMS-based system for oversight of laboratory developed procedures.
The session included presentations from various leaders in the field, all of whom are very knowledgeable regarding reimbursement for molecular diagnostic tests. "Defining and addressing the issues that prevent important clinical lab testing from being available to our patients will continue to be a major advocacy focus for AMP in 2016," said Samuel K. Caughron, MD, 2016 AMP Economic Affairs Committee Chair.
The session at the AMP 2015 Annual Meeting provided an update on the latest developments in Washington, DC. "What concerns me most about the direction that FDA is going with regulation of LDPs is that it will add to the significant economic burden that laboratories now face and slow their ability to develop new tests to respond to pressing public healthcare needs," said Congressman Burgess.
Brian J. Druker, MD, Director, Knight Cancer Institute will receive this year's AMP Award for Excellence. Congratulations to Dr. Druker and to AMP members Barbara A. Zehnbauer, PhD, and Roger D. Klein, MD, JD, for earning the Jeffrey A. Kant Leadership Award and the AMP Meritorious Service Award, respectively. They and other award winners will be honored at AMP 2015, November 5-7 in Austin, TX.
This month's issue is full of updates on AMP advocacy and educational initiatives as well as Annual Meeting highlights and innovative endeavors.
October 1, 2015: AMP article in the November issue of The Journal of Molecular Diagnostics, reviews NGS applications, challenges, and opportunities in infectious disease testing. "NGS holds enormous promise for clinical infectious diseases testing," said Benjamin Pinsky, MD, corresponding author.
August 4, 2015: Proposal provides assurance of quality, analytical validity, and clinical validity without jeopardizing innovation or patient access to necessary care in a tiered, risk-based structure that avoids duplication of activities within and between federal agencies.
June 4, 2015: The article, published in The Journal of Molecular Diagnostics, describes the current and future roles of the laboratory professional as genomic sequencing analysis becomes an ever more increasingly important tool in diagnostic medicine.
May 21, 2015: The AMP Board of Directors voted unanimously to launch an International Affairs Committee (IAC). The IAC stems from the International Affairs Working Group which, since 2010, has launched numerous successful education and collaboration opportunities with professionals and organizations outside the U.S.
April 20, 2015: May 2015 issue of JMD includes AMP article indicating that minimally invasive diagnostic techniques for cancer detection are promising and provide hope for enhanced patient care.